In This Section

NIH-AACR Cancer, Autoimmunity, and Immunology Conference


March 23-24, 2020
National Institutes of Health Masur Auditorium
Bethesda, Maryland

Abstract Submission DeadlineFriday, February 28, 2020, 11:59 p.m. ET
Registration DeadlineMonday, March 16, 2020


Organizing Committee

Julie R. Brahmer, Director, Thoracic Oncology Program and Upper Aerodigestive Clinical Research Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland
Elad Sharon, Senior Investigator, National Cancer Institute, Bethesda, Maryland
Connie Sommers, Program Director, National Cancer Institute, Bethesda, Maryland
Howard Young, Senior Investigator, National Cancer Institute, Bethesda, Maryland
Ravi Madan, Clinical Director, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
Katarzyna (Kasia) Bourcier, Program Officer, National Cancer Institute, Bethesda, Maryland
Marie Mancini, Program Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland
Annette Rothermel, Section Chief, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland
Lisa Spain, Program Director, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland

Held for the first time in 2018, the Cancer, Autoimmunity, and Immunology Conference was created to delve into 1) understanding the biology of immune-related, adverse events that have occurred in cancer patients treated with immunotherapies and how that might inform the study of autoimmune disease; and 2) defining the potential for the study of autoimmune-disease to lead to greater understanding of the treatment and management of immune-related adverse events during and following cancer therapies.

Professional Educational Grant

AstraZeneca

Merck


Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available


#aacrnihcai